This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lard, L R Articles by Huizinga, T W J Search for Related Content PubMed PubMed Citation Articles by Lard, L R Articles by Huizinga, T W J Social Bookmarking                   What's this?

Elevated IL-16 levels in patients with systemic lupus erythematosus are associated with disease severity but not with genetic susceptibility to lupus

Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands

B O Roep

Department of Immunohaematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands

C A Verburgh

Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands

A H Zwinderman

Department of Medical Statistics, Leiden University Medical Centre, Leiden, The Netherlands

T W J Huizinga

Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by several immunological abnormalities. The pathogenic importance of T cells in this disease is well established. Interleukin-16 (IL-16) is a cytokine which is mainly produced by CD8⁺ T cells and induces chemotaxis of CD4⁺ T cells and monocytes. IL-16 levels have been shown to be elevated in SLE patients in a cross-sectional study, but the mechanism is unknown. To explore whether the increased IL-16 levels are associated with genetic background or the disease itself, we investigated the IL-16 level in healthy first-degree family members of SLE patients and SLE patients who were followed over time with regard to disease activity. We observed high IL-16 levels in SLE patients with severe disease compared to SLE patients with non-severe disease and healthy controls. Furthermore, IL-16 levels in first-degree relatives were not different from those in healthy controls. These results suggest that high IL-16 levels are associated with severity of SLE, but not with genetic susceptibilityto SLE. Finally, we followed the disease activity of SLE patients over time, which showed significant correlation between the SLE disease activity index and IL-16, ESR and the complement components C3, C4 and CH50. In conclusion, these results implicate an association of IL-16 with SLE.

Key Words: IL-16 • systemic lupus erythematosus • severity • genetic predisposition

Lupus, Vol. 11, No. 3, 181-185 (2002)
DOI: 10.1191/0961203302lu176sr


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Rahangdale, R. Morgan, C. Heijens, T. C. Ryan, H. Yamasaki, E. Bentley, E. Sullivan, D. M. Center, and W. W. Cruikshank Chemokine Receptor CXCR3 Desensitization by IL-16/CD4 Signaling Is Dependent on CCR5 and Intact Membrane Cholesterol J. Immunol., February 15, 2006; 176(4): 2337 - 2345. [Abstract] [Full Text] [PDF]